Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

I

IKT

Inhibikase Therapeutics Inc

2.27

Aug 04 • 9:54 AM ET +0.06 (2.71%)

Healthcare Biotechnology USA Micro NASD

Peers: NBP NERV ALXO BCYC CGEN FATE FHTX CDXS NVCT AKTX

| Held by: VTI IWM IWN VXF VTWO IWC SBIO VTWV AVSC RSSL

Scroll to Statements

Index	RUT
Market Cap	299.71M
Enterprise Value	129.34M
Income	-50.96M
Sales	0.00M
Book/sh	1.27
Cash/sh	1.29
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	35
IPO	Dec 23, 2020

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	1.79
P/C	1.76
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	30.14
Current Ratio	30.14
Debt/Eq	0.00
LT Debt/Eq	0.00
Option/Short	No / Yes

EPS (ttm)	-0.43
EPS next Y	-0.45
EPS next Q	-0.11
EPS this Y	12.76%
EPS next Y	-4.09%
EPS next 5Y	6.39%
EPS past 3/5Y	51.48% 22.00%
Sales past 3/5Y	- -
EPS Y/Y TTM	73.45%
Sales Y/Y TTM	-100.00%
EPS Q/Q	37.76%
Sales Q/Q	-
Earnings	May 12 AMC
EPS/Sales Surpr.	7.66% -

Insider Own	24.61%
Insider Trans	0.00%
Inst Own	88.23%
Inst Trans	4.63%
ROA	-38.09%
ROE	-40.23%
ROIC	-30.40%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	4.49%
SMA50	17.19%
SMA200	28.03%
Trades

Shs Outstand	132.03M
Shs Float	99.54M
Short Float	18.35%
Short Ratio	21.62
Short Interest	18.26M
52W High	2.53 -10.28%
52W Low	1.33 70.68%
Volatility	6.43% 7.40%
ATR (14)	0.13
RSI (14)	60.08
Beta	0.95
Rel Volume	0.20
Avg Volume	844.74K
Volume	18,115

Perf Week	-1.73%
Perf Month	14.65%
Perf Quarter	17.01%
Perf Half Y	44.59%
Perf YTD	10.73%
Perf Year	41.87%
Perf 3Y	-8.84%
Perf 5Y	-82.48%
Perf 10Y	-
Recom	1.00
Target Price	6.00
Prev Close	2.21
Price	2.27
Change	2.71%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)